心力衰竭的预后沟通:经验,态度和实践的系统定性综合的协议
Christina Chu1, Steven Bloch2, Sarah Yardley3
1Marie Curie Palliative Care Research Department, University College London, London, UK christina.chu@ucl.ac.uk.
BMJ open
|November 5, 2025
概括
关于心力衰竭的预后性谈话很少发生,尽管它们对以人为中心的护理的重要性很大. 这份定性综合研究了患者和专业人士对这些重要讨论的经验.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 定性研究是指质量研究.
背景情况:
- 关于心力衰竭预期的过程的有效沟通对于以人为中心的护理至关重要.
- 临床指南建议在所有疾病阶段进行预后对话,但它们很少或迟发生.
- 这项研究解决了理解这些对话如何进行和经历的差距.
研究的目的:
- 探索目前围绕心力衰竭的预后对话的现行做法.
- 了解患者和医疗保健专业人员对预后讨论的态度.
- 综合参与预后沟通的个人的生活经验.
主要方法:
- 使用乔安娜·布里格斯研究所 (JBI) 的元聚合方法进行定性合成.
- 包括对预后性沟通经验,态度或心力衰竭实践的定性研究.
- 在多个数据库 (MEDLINE,EMBASE,PsycInfo,CINAHL,Web of Science,Overton,ProQuest,Google Scholar) 进行系统的文献搜索和参考选.
主要成果:
- 数据提取和质量评估由两名独立审核员使用JBI工具进行.
- 综合发现,汇总和总结预后对话的性质.
- 对总结结果的信心评估.
结论:
- 调查结果将揭示目前心力衰竭护理中的预后对话如何展开.
- 这份综合报告旨在为提高这些重要讨论的频率和质量的策略提供信息.
- 传播将通过同行评审的出版物进行,以推进临床实践和患者支持.
相关概念视频
Heart Failure VII: Nursing Interventions
408
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
408
Heart Failure IV: Classification and Diagnostic Evaluation
310
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
310
Heart Failure VI: Adjunct Therapies
245
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
245
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Heart Failure III: Clinical Manifestations
462
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
462
Heart Failure I: Introduction
673
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
673

